Maktav Dinçer

482 total citations
23 papers, 329 citations indexed

About

Maktav Dinçer is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Maktav Dinçer has authored 23 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Maktav Dinçer's work include Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and HER2/EGFR in Cancer Research (4 papers). Maktav Dinçer is often cited by papers focused on Breast Cancer Treatment Studies (10 papers), Breast Lesions and Carcinomas (5 papers) and HER2/EGFR in Cancer Research (4 papers). Maktav Dinçer collaborates with scholars based in Türkiye, India and United States. Maktav Dinçer's co-authors include Erkan Topuz, Adnan Aydıner, Pınar Saip, Gül Alço, Zafer Koçak, Mert Başaran, Kazım Uygun, Şefik İğdem, Sait Okkan and Vildan Yasasever and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Lancet Oncology and Gynecologic Oncology.

In The Last Decade

Maktav Dinçer

21 papers receiving 310 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maktav Dinçer Türkiye 12 113 99 91 85 60 23 329
H. Kolesnikov-Gauthier France 8 128 1.1× 54 0.5× 108 1.2× 69 0.8× 75 1.3× 19 387
E. Van Limbergen Belgium 8 98 0.9× 95 1.0× 73 0.8× 21 0.2× 98 1.6× 26 372
Douglas G. Gold United States 7 98 0.9× 28 0.3× 137 1.5× 34 0.4× 137 2.3× 10 323
Alina Abramian Germany 11 165 1.5× 67 0.7× 57 0.6× 63 0.7× 46 0.8× 30 372
Alain Labib France 11 275 2.4× 249 2.5× 124 1.4× 72 0.8× 194 3.2× 14 549
B. Pakisch Austria 8 104 0.9× 145 1.5× 68 0.7× 24 0.3× 67 1.1× 23 275
Mette Winderen Lindegaard Norway 8 109 1.0× 30 0.3× 121 1.3× 87 1.0× 111 1.9× 16 419
Noorie Choi South Korea 12 124 1.1× 87 0.9× 90 1.0× 18 0.2× 113 1.9× 22 319
Robyn Cheuk Australia 9 74 0.7× 20 0.2× 50 0.5× 104 1.2× 46 0.8× 26 322
Adnan Yöney Türkiye 11 65 0.6× 93 0.9× 83 0.9× 13 0.2× 110 1.8× 35 363

Countries citing papers authored by Maktav Dinçer

Since Specialization
Citations

This map shows the geographic impact of Maktav Dinçer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maktav Dinçer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maktav Dinçer more than expected).

Fields of papers citing papers by Maktav Dinçer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maktav Dinçer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maktav Dinçer. The network helps show where Maktav Dinçer may publish in the future.

Co-authorship network of co-authors of Maktav Dinçer

This figure shows the co-authorship network connecting the top 25 collaborators of Maktav Dinçer. A scholar is included among the top collaborators of Maktav Dinçer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maktav Dinçer. Maktav Dinçer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aydıner, Adnan, Soley Bayraktar, Ekrem Yavuz, et al.. (2019). A Review of Local and Systemic Therapy in Breast Cancer. Breast Disease. 637–690. 1 indexed citations
2.
Alço, Gül, Şefik İğdem, Sait Okkan, et al.. (2016). Replacement of the tumor bed following oncoplastic breast-conserving surgery with immediate latissimus dorsi mini-flap. Molecular and Clinical Oncology. 5(4). 365–371. 21 indexed citations
3.
Ordu, Çetın, Kandace P. McGuire, Gül Alço, et al.. (2016). The Prognostic Impact of Molecular Subtypes and Very Young Age on Breast Conserving Surgery in Early Stage Breast Cancer. Cureus. 8(6). e633–e633. 6 indexed citations
4.
Ordu, Çetın, Gül Alço, Kezban Nur Pilancı, et al.. (2016). True Local Recurrences after Breast Conserving Surgery have Poor Prognosis in Patients with Early Breast Cancer. Cureus. 8(3). e541–e541. 7 indexed citations
5.
Alço, Gül, Kezban Nur Pilancı, Sıtkı Tuzlalı, et al.. (2015). Clinical and histopathological factors associated with Ki-67 expression in breast cancer patients. Oncology Letters. 9(3). 1046–1054. 23 indexed citations
7.
Alço, Gül, Şefik İğdem, Maktav Dinçer, et al.. (2014). Vitamin D Levels in Patients with Breast Cancer: Importance of Dressing Style. Asian Pacific Journal of Cancer Prevention. 15(3). 1357–1362. 18 indexed citations
8.
Girgin, Sadullah, Atilla Soran, Nilüfer Güler, Maktav Dinçer, & Gökhan Demir. (2014). Is Completion Axillary Dissection Necessary For This Patient?. SHILAP Revista de lepidopterología. 10(3). 184–188.
9.
İğdem, Şefik, et al.. (2010). Dosimetric comparison of field in field intensity-modulated radiotherapy technique with conformal radiotherapy techniques in breast cancer. Japanese Journal of Radiology. 28(4). 283–289. 33 indexed citations
10.
Atahan, Lale, Ferah Yıldız, Mustafa Cengiz, et al.. (2009). Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study. Supportive Care in Cancer. 18(6). 691–698. 14 indexed citations
11.
Saip, Pınar, İrfan Çiçin, Yeşim Eralp, et al.. (2008). Identification of patients who may benefit from the prophylactic cranial radiotherapy among breast cancer patients with brain metastasis. Journal of Neuro-Oncology. 93(2). 243–251. 14 indexed citations
12.
Uygun, Kazım, Adnan Aydıner, Pınar Saip, et al.. (2003). Granulosa Cell Tumor of the Ovary. American Journal of Clinical Oncology. 26(5). 517–521. 50 indexed citations
13.
Uygun, Kazım, Adnan Aydıner, Pınar Saip, et al.. (2003). Clinical parameters and treatment results in recurrent granulosa cell tumor of the ovary. Gynecologic Oncology. 88(3). 400–403. 38 indexed citations
14.
Özmen, Vahit, Neslihan Cabıoğlu, Abdullah İğci, et al.. (2003). Inflammatory Breast Cancer: Results of Antracycline-Based Neoadjuvant Chemotherapy. The Breast Journal. 9(2). 79–85. 3 indexed citations
15.
Dinçer, Maktav, et al.. (2001). One hundred years of radiotherapy in Turkey. The Lancet Oncology. 2(10). 631–633.
16.
Dinçer, Maktav. (2001). International Society for The History of Islamic Medicine. The Lancet Oncology. 2(11). 707–707. 3 indexed citations
17.
Yasasever, Vildan, Maktav Dinçer, Hakan Çamlıca, Derya Duranyıldız, & Nejat Dalay. (2000). Serum c-erb B2 oncoprotein levels are elevated in recurrent and metastatic breast cancer. Clinical Biochemistry. 33(4). 315–317. 3 indexed citations
18.
Saip, Pınar, et al.. (1999). Response Evaluation of Bone Metastases in Breast Cancer: Value of Magnetic Resonance Imaging. Cancer Investigation. 17(8). 575–580. 14 indexed citations
19.
Yasasever, Vildan, et al.. (1997). Utility of CA 15-3 and CEA in monitoring breast cancer patients with bone metastases: Special emphasis on “spiking” phenomena. Clinical Biochemistry. 30(1). 53–56. 32 indexed citations
20.
Kurul, Sıdıka, et al.. (1997). Plastic surgery in irradiated areas: analysis of 200 consecutive cases. European Journal of Surgical Oncology. 23(1). 48–53. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026